
This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

A 24-week randomized clinical trial found PRT-P led to improvements in social communication skills among children with ASD.

As patients age, they become more susceptible to the cyclical factors that can drive insomnia severity.

Socially active people in the their 50s and 60s have a lower risk of developing dementia, according to a new study.

Days after another couple of mass shooting tragedies, a team of psychiatry thought leaders discuss the public's understanding of mental health care.

New model predicts patients at risk of developing Alzheimer disease up to 2 years in the future.

An overview of exciting, upcoming therapies that may be of interest for the treatment of Alzheimer disease.

Experts discuss the status of clinical trials that explore various monoclonal antibody therapies and BACE inhibitors for the treatment of Alzheimer disease.

A conventional mass-univariate fMRI analysis helps determine patients that exhibit greater pretreatment neural activity.

Sunovion seeking FDA approval for dateline after successful clinical trials treating binge eating disorder.

A cohort study analysis shows clozapine is effective in treating schizophrenia, despite adverse effects.

The rationale for investigating monoclonal antibodies and BACE inhibitors for the treatment of patients with Alzheimer disease.

Drs. Alireza Atri and Ronald C. Petersen remark on the important roles a community neurologist, as well as other members of a patient’s health care team, can play in the management of Alzheimer disease.

The fourth version of the Cleveland Clinic’s Alzheimer pipeline includes 156 clinical trials and 132 agents currently in all 3 phases of clinical trials in the US.

New study breaks down initial antipsychotic prescriptions among young, ADHD patients.

The role of clinical trials and the importance of counseling patients on trial enrollment and lifestyle interventions in the management of Alzheimer disease.

What resources shaped the most recent #DocTalk Tweet Chat on finding solutions in the physician burnout epidemic?

Both motor and non-motor symptoms improve using ear stimulation can help manage Parkinson symptoms.

New research shows esketamine nasal spray could help treat patients who do not respond to antidepressants.

Expert clinicians highlight current unmet needs surrounding the treatment of Alzheimer disease.

New research finds association common sleep disorder present in 14% of suicidal patients with major depressive disorder studied.

Burnout non-profit founder Janae Sharp will lead a chat on what's working in addressing physician burnout—and what's still lacking.

Intec Pharma announces clinical trial failure after finding new drug did not have a market difference treating PD from existing medications.

New research shows keeping a diary while in the ICU does not prevent PTSD symptoms from occurring.

Several new generics available to treat neuropathic pain linked to diabetic peripheral neuropathy, fibromyalgia partial onset seizures, and other conditions.